GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of Ozempic (semaglutide) and Wegovy (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx,

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor

Almost 800 medications—including Ozempic and Mounjaro—had a median list price increase of 4.5% this month, according to a Wall Street Journal report, meaning copays may increase for consumers.

At a list price of about $1,080 per month, Lilly's drugs also undercut Novo's official pricing. Ozempic accidentally became a cultural phenomenon. The drug, first delivered to diabetes patients in 2017, had a huge impact on appetite suppression and weight ...

Ozempic price slashed following Donald Trump's demands - will it impact the UK cost? - Novo Nordisk said it has no plans to rise UK prices, despite pressure from Trump